Michael Samarkos
Impact in
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research
- Osteomyelitis and Bone Disorders Research
Papers in
-
- COVID-19 Clinical Research Studies 6
- Epidemiology 12
- Pneumonia and Respiratory Infections 3
- Co-authors
- Panagiotis Fanourgiakis (7 shared papers)Athanassios Skoutelis (1 shared paper)Eugenia Mylona (1 shared paper)Eleni Kakalou (1 shared paper)George Vaiopoulos (9 shared papers)Haralampos Μ. Moutsopoulos (2 shared papers)S. Loizou (4 shared papers)Kevin Davies (4 shared papers)
- Journals
- Antibiotics (4 papers)Seminars in Arthritis and Rheumatism (3 papers)Lara D. Veeken (2 papers)The American Journal of Medicine (2 papers)International Journal of Antimicrobial Agents (2 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Michael Samarkos
66 papers receiving 1.6k citations
Michael Samarkos's Hit Papers
Peers
Comparison fields: 5 of 95
- Rheumatology 392
- Applied Microbiology and Biotechnology 32
- Hematology 166
- Infectious Diseases 237
- Surgery 534
Countries citing papers authored by Michael Samarkos
This map shows the geographic impact of Michael Samarkos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Samarkos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Samarkos more than expected).
Fields of papers citing papers by Michael Samarkos
This network shows the impact of papers produced by Michael Samarkos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Samarkos. The network helps show where Michael Samarkos may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Samarkos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pyogenic Vertebral Osteomyelitis: A Systematic Review of Clinical Characteristics Hit paper breakdown → | 2008 | 451 |
| 2 | 2007 | 179 | |
| 3 | 2021 | 90 | |
| 4 | 2019 | 80 | |
| 5 | 2018 | 57 | |
| 6 | 1998 | 55 | |
| 7 | 2005 | 51 | |
| 8 | 2010 | 47 | |
| 9 | 2021 | 46 | |
| 10 | 2005 | 45 | |
| 11 | 2017 | 43 | |
| 12 | 2005 | 33 | |
| 13 | 2000 | 28 | |
| 14 | 2001 | 28 | |
| 15 | 2012 | 26 | |
| 16 | 2018 | 23 | |
| 17 | 2007 | 23 | |
| 18 | 2004 | 22 | |
| 19 | 2006 | 20 | |
| 20 | 2005 | 19 |
About Michael Samarkos
Michael Samarkos is a scholar working on Infectious Diseases, Epidemiology, Rheumatology, Oncology and Surgery, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (7 papers), COVID-19 Clinical Research Studies (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (5 papers), Vasculitis and related conditions (3 papers), Pneumonia and Respiratory Infections (3 papers) and Rabies epidemiology and control (3 papers). The work is most often cited by research in Rheumatology (392 citations), Applied Microbiology and Biotechnology (32 citations), Hematology (166 citations), Infectious Diseases (237 citations) and Surgery (534 citations). Michael Samarkos has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Panagiotis Fanourgiakis, Athanassios Skoutelis, Eugenia Mylona, Eleni Kakalou, George Vaiopoulos, Haralampos Μ. Moutsopoulos, S. Loizou, Kevin Davies, V. Votteas and Ioannis Moyssakis. Their work appears in journals such as Antibiotics, Seminars in Arthritis and Rheumatism, Lara D. Veeken, The American Journal of Medicine and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.